Home > Name List By 5 > 5-[(E)-2-bromoethenyl]-1-[(2R,3S,4S,5R)-3, 4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione

CAS No 77181-69-2 , 5-[(E)-2-bromoethenyl]-1-[(2R,3S,4S,5R)-3,
4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione

  • Name: 5-[(E)-2-bromoethenyl]-1-[(2R,3S,4S,5R)-3,
    4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione
  • Synonyms: Bravavir; BV-Ara-U; Brovavir; Usevir;5-[(E)-2-bromoethenyl]-1-[(2R,3S,4S,5R)-3,
    4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione; BVAU; Bromovinyluridine; BV-araU; YN-72; 5-Bromovinyl-araU;
  • CAS Registry Number:
  • Density: 1.979g/cm3
  • Refractive index: 1.746
  • Molecular Weight: 349.13472
  • InchiKey: GCQYYIHYQMVWLT-HQNLTJAPSA-N
  • InChI: InChI=1S/C11H13BrN2O6/c12-2-1-5-3-14(11(19)13-9(5)18)10-8(17)7(16)6(4-
    15)20-10/h1-3,6-8,10,15-17H,4H2,(H,13,18,19)/b2-1+/t6-,7-,8+,10-/m1/s1
  • Molecular Formula: C11H13BrN2O6
  • Molecular Structure:CAS No:77181-69-2 5-[(E)-2-bromoethenyl]-1-[(2R,3S,4S,5R)-3,<br />4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione

Related products

Search by region :

Select to

77181-69-2 Sorivudine

  • United States LGM Pharma [Manufacturer]
  • Tel: 561-981-9994
  • Fax: 561-892-0580
  • Address: 922 Clint Moore Road
    Boca Raton, FL 33487 null,nullUnited States
Contact Supplier

77181-69-2 SORIVUDINE

  • China Nanjing Chemlin Chemical Industry Co.,Ltd. [Manufacturer]
  • Tel: +86 25 8369-7070/ +86 138 51816776 (Mobile)
  • Fax: +86 25 8345-3275
  • Address: Rm.902 Longyin Plaza,
    No. 217 Zhongshan Rd.
    (N)Nanjing 210009,China null,nullChina
Contact Supplier

Select to

1/1
References of 5-[(E)-2-bromoethenyl]-1-[(2R,3S,4S,5R)-3,
4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione
Title: Sorivudine
CAS Registry Number: 77181-69-2
CAS Name: 1-b-D-Arabinofuranosyl-5-[(1E)-2-bromoethenyl]-2,4(1H,3H)-pyrimidinedione
Synonyms: 1-b-D-arabinofuranosyl-(E)-5-(2-bromovinyl)uracil; 5-bromovinyl-araU; brovavir; BV-araU; BVAU
Manufacturers' Codes: YN-72; SQ-32756
Trademarks: Usevir (Yamasa Shoyu)
Molecular Formula: C11H13BrN2O6
Molecular Weight: 349.13
Percent Composition: C 37.84%, H 3.75%, Br 22.89%, N 8.02%, O 27.50%
Literature References: Orally active antiviral agent; inhibits viral DNA synthesis. Prepn: H. Machida, S. Sakata, EP 31128; eidem, US 4386076 (1981, 1983 both to Yamassa Shoyu); S. Sakata et al., Nucleic Acids Symp. Ser. 8, s39 (1980); R. Busson et al., ibid. 9, 49 (1981). Antiviral activity and toxicity: H. Machida, S. Sakata, Antiviral Res. 4, 135 (1984). Mechanism of action studies: T. Yokota et al., Mol. Pharmacol. 36, 312 (1989); H. Machida, Adv. Exp. Med. Biol. 278, 255 (1990). Clinical trial in herpes zoster infection: M. Niimura, ibid. 267.
Properties: mp 182° (Sakata, 1980); also reported as white crystals from ethanol, mp 195-200° (dec) (Machida, Sakata, 1983). [a]D25 +0.5° (1N NaOH). LD50 in mice (mg/kg): ~3300 i.p.; >5000 s.c.; >10000 orally (Machida, Sakata, 1984).
Melting point: mp 182° (Sakata, 1980); mp 195-200° (dec) (Machida, Sakata, 1983)
Optical Rotation: [a]D25 +0.5° (1N NaOH)
Toxicity data: LD50 in mice (mg/kg): ~3300 i.p.; >5000 s.c.; >10000 orally (Machida, Sakata, 1984)
Therap-Cat: Antiviral.
Keywords: Antiviral; Purines/Pyrimidinones.